*As of January 2017, note that there will be no further open competitions for the Translational Research Program.*
The John Merck Fund has had a longstanding interest in people with intellectual and developmental disorders since its inception in 1970. In 2012, JMF launched the Developmental Disabilities Translational Research Program, which supports researchers in developing treatments and improving outcomes for individuals with developmental disabilities, particularly Down syndrome and Fragile X syndrome (and FX associated disorders). The awards are made to the most highly innovative translational research projects that have the greatest potential of investigating rational and effective treatments and interventions for the particular condition being addressed. The program emphasizes interdisciplinary collaborative grant applications focused primarily on FXS and DS. The Fund is particularly interested in translational research that is designed to improve the lives of people with developmental disabilities and their families.
Since 2012, the Translational Research Program has approved seven awards of $1 million each ($250,000 per year for four years). For a list of the TRP grants, click here.
The final competition of the Translational Research Program will be through a Request for Proposal process. Details will be available on this website later in 2017.
For more information about the Translational Research Program, contact Nancy Stockford, The John Merck Fund, 2 Oliver Street, 8th Floor, Boston, MA 02109; email@example.com; telephone: (617) 556-4120.